Cure® adds a Chief Operating Officer, Chief Financial Officer and Vice President of Industry Programs and Sponsorships to its senior leadership team

Charles KimMBA, appointed chief operating officer and chief financial officer

Susan Ling named senior vice president of industry programs, sponsorships and partnerships

NEW YORK, June 20, 2024 /PRNewswire/ — Cure.^®healthcare innovation campus in New Yorkannounced today Charles KimMBA, as the new chief operating officer (COO) and chief financial officer (CFO), and Susan Ling as the new senior vice president of industry programs, sponsorships and partnerships. Kim and Ling report to the CEO Seema Kumar in newly created senior management positions.

Kim joins Cure with extensive experience successfully scaling startups and driving and optimizing organic and inorganic revenue growth. Ling brings to Cure expertise in managing international biotech, pharmaceutical and nonprofit partnerships and sponsorships, including developing, managing and marketing campaigns, initiatives and programming.

“I am delighted to add Charles’ operational and financial experience, as well as Susanna’s expertise in building strong alliances, to Cure,” he said The director heals Seema Kumar. These will help drive Cure’s continued growth into a hub for healthcare innovation and a destination for healthcare entrepreneurs. Both Charles and Susanna are uniquely qualified to support Cure’s current and future efforts, helping us build an ecosystem of excellence in healthcare entrepreneurship.”

Kim previously served as chief operating officer of Full Circle Brands, executive vice president and co-chief operating officer of Ascend Wellness Holdings, and vice president of distribution and logistics for Freshly (Nestle). Kim earned a bachelor’s degree in political science and economics from the University of University of Chicago and an MBA from the Kellogg School of Management at ul Northwest University.

“I am excited to join Cure and leverage my financial and operational skills and expertise to help generate profitable growth and operational excellence, all while supporting its mission to improve health,” said Kim.

Ling previously served as vice president of industry partnerships and sponsorships at the Biotechnology Innovation Organization (BIO), vice president of business and program development at EBD Group/Informa, and on management teams at Milken Institute/Faster Cures, Guildford Pharmaceuticals, MedImmune, and the National Cancer Institute . Ling earned her bachelor’s degree in biology from U.S Rutgers University.

“I am excited to expand the Cure partnership, expand our digital ecosystem and create new programming to complement our Tuesday Talks series, Xchange Challenge, XSeed Award, workshops and other initiatives. By leveraging Cure’s shared mission with the life sciences, patient advocacy and investment communities, our goal is to advance areas such as women’s health, biotech entrepreneurship, rare diseases, cell/gene therapy and more for the benefit of patients,” Ling said.

Oh Cure.
Cure is a vibrant healthcare innovation campus located in the heart of the city New York with a mission to improve health. Supporting entrepreneurs in the healthcare and life sciences industries, Cure offers digital and in-person content, programs and knowledge on key health and business topics. The campus at 345 Park Avenue South includes laboratory and business facilities, office space and top-notch event spaces, including an education center, conference center and iconic rooftop terrace. Residents and fellows collaborate across the health care spectrum and focus on diagnostics, devices, drug development and manufacturing, as well as care delivery and public health. For more information please visit wewillcure.com.

SOURCE Medicine